|
Advances in non tuberculous mycobacteria and new risks for public health
21 January 2025 @ 10.00 - 11.00 CET
Dr Emmanuelle Cambau will provide an insightful overview of non-tuberculous mycobacteria, highlighting what’s new on the horizon, while Dr Jakko van Ingen will present an update on the diagnosis and treatment of Mycobacterium abscessus infections which are increasing particularly in immunocompromised patients or those with comorbidities. This is a must-attend event for anyone interested in the latest developments and challenges in this evolving field.
REGISTER
Programme
Overview of non-tuberculous mycobacteria: what is new on the horizon
Dr Emmanuelle Cambau (University Paris Cité / Hospitals of Paris, France)
Update on diagnosis and treatment of M. abscessus infections
Prof. Jakko van Ingen (Radboud University Medical Center, Netherlands
Moderators:
Prof. Souha Kanj (ISAC President / American University of Beirut Medical Center, Lebanon)
Prof. David Jenkins (ISAC Treasurer / University Hospitals of Leicester NHS Trust, UK)
---------------------------------------------
Introducing the Abx Guide: Africa region
22 January 2025 @ 11.00 - 12.00 CET
We invite you to the final regional webinar in the series to launch the Abx Guide: an open-access antibiotic treatment-guide focused on pathogen-directed treatment for resource-constrained settings.
This series of webinars delves into the relevance of the ABX Guide and the development process behind its treatment recommendations. We explore its application across various geographic regions, featuring speakers who highlight related projects and initiatives.
This webinar will focus on the Africa region and will feature a talk from Prof. Natalie Schellack on "Making the case for patient safety in stewardship practices".
REGISTER
ISAC in collaboration with Radboud university medical centre (Radboudumc), the Netherlands and the American University of Beirut Medical Centre (AUBMC), Lebanon developed an open access online antimicrobial treatment guideline for global application (ISAC AbxGuide) intended to provide guidance on antibiotic treatment of common infectious diseases in an easy-to-use modular format that can be adapted to different settings. The main aim is to address the gaps causing inappropriate antibiotic use in low-resource settings.
The content is intended to be as much as possible applicable to all settings taking into consideration evidence-based medicine including clinical studies and international guidelines and where possible using pragmatic priority listing between alternative treatment options. The gathered evidence of directed treatment advice for the major bacterial infectious diseases and resistance phenotypes will be presented in a free-access online interactive ISAC AbxGuide platform.
ACCESS THE ABX GUIDE
------------------------------------------
ISAC is now on Bluesky!
Follow us at ISACworld.bsky.social
|
